Cardio-Oncology

 A thorough understanding of cardio-oncology is very essential for the effective treatment of cancer patients. Virtually all antineoplastic agents are related with cardiotoxicity. All patients who are being considered for chemotherapy, particularly the individuals who have earlier history of heart sickness ought to experience point by point cardiovascular assessment to advance the treatment. Sequential examination of left ventricular systolic function and cardiac biomarkers might also be considered in the selected populations of patient. Cardio-toxic effects of chemotherapy can be decreased by the frequent use of angiotensin-converting inhibitors of enzyme, angiotensin receptor blockers, or beta-blockers. Antiplatelet or anticoagulation therapy may be taken in patients with a potential hyper-coagulable state related with chemotherapy or malignant growth

    Related Conference of Cardio-Oncology

    June 11-12, 2024

    31st Global Nursing and Health Care Conference

    Amsterdam, Netherlands
    June 20-21, 2024

    55th World Nursing and Healthcare Conference

    Dublin, Ireland
    June 27-28, 2024

    61st World Nursing Conference

    London, UK
    July 18-19, 2024

    31st Global Nursing and Healthcare Congress

    Paris, France
    August 08-09, 2024

    43rd World Nursing and Healthcare Conference

    London, UK
    September 04-05, 2024

    World Nursing Congress

    Toronto, Canada
    October 10-11, 2024

    16th International Conference on Gynecology

    Madrid, Spain
    December 04-05, 2024

    4th Global Summit on Nursing Practice

    Orlando, USA

    Cardio-Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in